ACRS
Aclaris Therapeutics Inc
Sign up for free!
Get instant access to stock market data and news with our free APIs.
Real-time data
- Listing exchange
- NASDAQ Stock Exchange
- Price
- $8.78
- Day High
- $9.12
- Day Low
- $8.5
- Day Open
- $8.56
- Volume
- 28008
- Day Change
- 0.8%
Latest news data for ACRS
Aclaris Therapeutics to Participate in Two June Healthcare Investor Conferences
globenewswire.com
Aclaris Therapeutics, Inc. (ACRS) Q1 2023 Earnings Call Transcript
seekingalpha.com
Aclaris Therapeutics (ACRS) Reports Q1 Loss, Tops Revenue Estimates
zacks.com
Aclaris Therapeutics GAAP EPS of -$0.42 beats by $0.02, revenue of $2.53M beats by $0.78M (NASDAQ:ACRS)
seekingalpha.com
Aclaris Therapeutics Reports First Quarter 2023 Financial Results and Provides a Corporate Update
globenewswire.com
Aclaris Therapeutics to Announce First Quarter 2023 Financial Results on May 8, 2023
globenewswire.com
Seborrheic keratosis treatment market size to grow by USD 786.38 million between 2021 and 2026; Aclaris Therapeutics Inc., BioLineRx Ltd., among others, identified as key vendors - Technavio
prnewswire.com
Aclaris Therapeutics to Participate in the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
globenewswire.com
Global Alopecia Market Size To Grow USD 13.7 Billion By 2030 | CAGR 7.7%
globenewswire.com
Aclaris Therapeutics (ACRS) Stock: Potential Speculative Play
seekingalpha.com